The expertise of Robert Dreicer ranks in the
Graphical view (beta)
Hide
Longer horizontal black lines means more people have that level of expertise.
Expertise level forRobert Dreicer |
|
|
|
|
Higher
Amount of
expertise
(logarithmic)
Lower
|
|
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
|
| Most likely: |
|
|
University of Virginia |
|
|
|
| 2017 | - University of Virginia, Charlottesville, VA 22908, USA. Electronic address: · Pubmed 28967486
- University of Virginia Cancer Center, Department of Medicine, University of Virginia, Box 800716, 6261 Multi-Story Building, Charlottesville, VA 22908, USA. Electronic address: · Pubmed 28389317
|
| 2016 | - Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22908, USA. Electronic address: · Pubmed 27733242
- Oregon Health & Science University, Portland, Oregon. Electronic address: · NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania. · Massachusetts General Hospital, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · University of Virginia, Charlottesville, Virginia. · University of Vermont College of Medicine, Burlington, Vermont. · McGill University Health Centre, Montreal, Québec, Canada. · University of Alabama at Birmingham, Birmingham, Alabama. · Cedars-Sinai Medical Center, Los Angeles, California. · Pubmed 26700703
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Probable: |
|
|
Miscellaneous institutions in Chicago |
|
|
|
| 2017 | - American Urological Association Education and Research, Inc., Linthicum, Maryland; American Society of Clinical Oncology, Alexandria, Virginia; American Society for Radiation Oncology, Arlington, Virginia; Society of Urologic Oncology, Inc., Schaumburg, Illinois. · Pubmed 28456635
|
|
| Probable: |
|
|
Cleveland Clinic |
Contact |
|
|
| 2015 | - Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25447103
|
| 2014 | - Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. · Pubmed 24332124
- Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Department of Pathology, University of California at San Diego, La Jolla, CA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA. · Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA. · Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH. · Scott Department of Urology, Baylor College of Medicine, Houston, TX. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Quest Diagnostics, San Juan Capistrano, CA. · Department of Preventive Medicine, University of Southern California, Los Angeles, CA. · Department of Pathology, University of Washington Medical Center, Seattle, WA. · Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA. · Department of Surgery-Urology, The University of Colorado, Denver, CO. · National Cancer Institute, Bethesda, MD. · Department of Medicine Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25443274
|
| 2013 | - Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA. · Pubmed 23687794
|
| 2009 | - Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 19536901
|
| 2008 | - Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 18459175
|
| 2013 | - Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 23403633
|
| 2011 | - Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 21516078
|
| 2009 | - Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195-0001, USA. · Pubmed 19127557
|
| 2008 | - Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 18628098
|
|
Show MoreFewer
| Possible: |
|
|
University of Michigan |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
| 2009 | - University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · Pubmed 19858384
|
|
| Possible: |
|
|
Harvard University |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Vanderbilt University |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Virginia Commonwealth University |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Baylor Scott and White Health System |
|
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Veterans Health System |
|
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
University of Texas Houston |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
University of Kansas School of Medicine |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
University of Texas Southwestern |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Northwestern University |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Baylor College of Medicine |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Washington University |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Memorial Sloan-Kettering Cancer Center |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Oregon Health Sciences University |
Contact |
|
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
| Possible: |
|
|
Mount Sinai New York |
Contact |
|
|
| 2013 | - Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY 10029, USA. · Pubmed 23456777
|
|
| Possible: |
|
|
San Camillo-Foranini Hospitals |
|
|
|
| 2013 | - Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 22917984
|
|
| Possible: |
|
|
University College Dublin |
|
|
|
| 2011 | - Department of Surgery, Mater Misericordiae Hospital and University College Dublin, Dublin, Ireland. · Pubmed 21382149
|
|
|
|
In the titles of their published articles, experts often reveal their very specific interests.
Here
are the titles of the 10 most recent articles
(out of 22 total) written by Robert Dreicer
about Urinary Bladder Neoplasms:
- Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary. 2017
- Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. 2017
- New option for cisplatin-ineligible urothelial cancer. 2017
- Chemotherapy for advanced urothelial cancer: end of the beginning? 2017
- Immunomodulatory treatment in urothelial cancer. 2016
- Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233. 2016
- Interdisciplinary management of locally advanced and metastatic genitourinary cancers: a team sport. 2015
- Editorial comment. 2014
- Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum. 2014
- ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings. 2013
Show List of Full Article Records
|
|
Learn more about Robert Dreicer using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!
| General Search: |
|
| University of Virginia |
|
|
| Miscellaneous institutions in Chicago |
|
|
| Cleveland Clinic |
|
|
|
|
Click for institutional directory in table below. (Not always available.)
What is this?
|
|
|
|
University of Virginia
|
| | |
|
| 2017 | - University of Virginia, Charlottesville, VA 22908, USA. Electronic address: · Pubmed 28967486
- University of Virginia Cancer Center, Department of Medicine, University of Virginia, Box 800716, 6261 Multi-Story Building, Charlottesville, VA 22908, USA. Electronic address: · Pubmed 28389317
|
| 2016 | - Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22908, USA. Electronic address: · Pubmed 27733242
- Oregon Health & Science University, Portland, Oregon. Electronic address: · NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania. · Massachusetts General Hospital, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · University of Virginia, Charlottesville, Virginia. · University of Vermont College of Medicine, Burlington, Vermont. · McGill University Health Centre, Montreal, Québec, Canada. · University of Alabama at Birmingham, Birmingham, Alabama. · Cedars-Sinai Medical Center, Los Angeles, California. · Pubmed 26700703
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Miscellaneous institutions in Chicago
|
| | |
|
| 2017 | - American Urological Association Education and Research, Inc., Linthicum, Maryland; American Society of Clinical Oncology, Alexandria, Virginia; American Society for Radiation Oncology, Arlington, Virginia; Society of Urologic Oncology, Inc., Schaumburg, Illinois. · Pubmed 28456635
|
|
|
|
|
Cleveland Clinic
|
| | |
|
| 2015 | - Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25447103
|
| 2014 | - Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. · Pubmed 24332124
- Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Department of Pathology, University of California at San Diego, La Jolla, CA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA. · Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA. · Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH. · Scott Department of Urology, Baylor College of Medicine, Houston, TX. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Quest Diagnostics, San Juan Capistrano, CA. · Department of Preventive Medicine, University of Southern California, Los Angeles, CA. · Department of Pathology, University of Washington Medical Center, Seattle, WA. · Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA. · Department of Surgery-Urology, The University of Colorado, Denver, CO. · National Cancer Institute, Bethesda, MD. · Department of Medicine Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25443274
|
| 2013 | - Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA. · Pubmed 23687794
|
| 2009 | - Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 19536901
|
| 2008 | - Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 18459175
|
| 2013 | - Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 23403633
|
| 2011 | - Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 21516078
|
| 2009 | - Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195-0001, USA. · Pubmed 19127557
|
| 2008 | - Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 18628098
|
|
|
|
|
17 Other Locations
Show
Hide
|
| | |
|
|
|
| Yearly article counts |
0 | 0 | 4 | 2 | 1 | 2 | 4 | 1 | 2 | 0 | 3 | 3 |
|
|
|
|
University of Michigan
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
| 2009 | - University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · Pubmed 19858384
|
|
|
|
|
Harvard University
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Vanderbilt University
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Virginia Commonwealth University
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Baylor Scott and White Health System
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Veterans Health System
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
University of Texas Houston
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
University of Kansas School of Medicine
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
University of Texas Southwestern
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Northwestern University
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Baylor College of Medicine
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Washington University
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Memorial Sloan-Kettering Cancer Center
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Oregon Health Sciences University
|
| | |
|
| 2017 | - Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS. · Pubmed 28796558
|
|
|
|
|
Mount Sinai New York
|
| | |
|
| 2013 | - Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY 10029, USA. · Pubmed 23456777
|
|
|
|
|
San Camillo-Foranini Hospitals
|
| | |
|
| 2013 | - Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 22917984
|
|
|
|
|
University College Dublin
|
| | |
|
| 2011 | - Department of Surgery, Mater Misericordiae Hospital and University College Dublin, Dublin, Ireland. · Pubmed 21382149
|
|
|
| Yearly article counts |
0 | 0 | 4 | 2 | 1 | 2 | 4 | 1 | 2 | 0 | 3 | 3 |
|
|
You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape
"Saved Pages" page, which is always easily available
from the page-top menu bar throughout the site.
|
